Search Medical Condition
Please enter condition
Please choose location from dropdown
Clear Trial Filters

Nanjing,, China Clinical Trials

A listing of Nanjing,, China clinical trials actively recruiting patients volunteers.

RESULTS

Found (9) clinical trials

Insomnia Treated by Traditional Chinese Medicine and Its Circadian Rhythm

To record the demographic information and clinical characteristics of participants, including age, gender, education background, and drug use. Venous blood samples were collected and sent to laboratory test for blood routine, blood biochemistry, and blood homocysteine before and after 1 months of treatment. The remaining blood samples were kept in …

Phase N/A

0.0 miles

Learn More »

Phase II Study of Hemay007 in Patients With Active Ulcerative Colitis

his study adopts a multicenter, randomized, double-blind, low-medium-high dose group and placebo parallel controlled clinical study design. After screening, patients with active ulcerative colitis who meet the inclusion criteria and do not meet the exclusion criteria will be randomized by 1:1:1:1 to Hemay007 400 mg BID group, 800 mg QD …

Phase

0.0 miles

Learn More »

An Epidemiologic Study on PD-L1 Expression Combined With Clinical Observation in the Chinese MIUBC Patients.

The primary objective of this observational study is: To investigate the prevalence of high PD-L1 expression in Chinese MIUBC patients. High PD-L1 expression is defined as 25% tumor cell membrane positivity for PD-L1 at any intensity above background staining as noted on the corresponding negative control OR 25% tumor associated …

Phase N/A

0.0 miles

Learn More »

A Study of TQ-B3525 in the Treatment of Relapsed / Refractory Follicular Lymphoma (FL)

The objective of this study is to evaluate the efficacy of TQ-B3525 in patients with relapsed / refractory follicular lymphoma.

Phase

0.0 miles

Learn More »

A Study of Surufatinib Plus Sintilimab in Patients With Advanced Solid Tumor

The purpose of this study is to evaluate the safety and efficacy of Surufatinib plus Sintilimab in Patients with Advanced Solid Tumor

Phase

0.0 miles

Learn More »

Intestinal Flora Research Plan for Critically Ill Patients

With the improvement and development of medical technology and concepts, the types, progression, and outcomes of critically ill patients have changed dramatically. More and more critically ill patients can successfully escape from the early critical state, and the outbreak of multiple organ failure has been alleviated. However, due to the …

Phase N/A

0.68 miles

Learn More »

Education Program for Care Home Staff

The competence of care home staff in dementia care is highly influential to the quality of care that adversely affects both people living with dementia and staff and in Mainland China where knowledge on dementia among care home staff was generally poor and this area is under-researched. This study aims …

Phase N/A

2.28 miles

Learn More »

A Study of TQB2450 in Subjects With Stage III Non-Small Cell Lung Cancer(NSCLC)

This study is a randomized, double-blind, double-dummy,placebo parallel controlled, multi-centre,phase III clinical trial to evaluate the efficacy and safety of TQB2450 with or without anlotinib compared with placebo as consolidation treatment in subjects with locally advanced/unresectable (Stage III) Non-Small Cell Lung Cancer that has not progressed after prior concurrent/sequential chemoradiotherapy.

Phase

2.28 miles

Learn More »

Soluble ST2 and Cardiovascular Outcome

Cardiac surgery induces hemodynamic stress on the myocardium, and this process can be associated with significant cardiovascular morbidity and mortality. Soluble suppression of tumorigenicity 2 (sST2) is biomarker of myocardial remodeling and fibrosis; however, little is known regarding their potential association with cardiovascular events. This study aimed to investigate the …

Phase N/A

2.28 miles

Learn More »